Agilent Technologies last week launched GeneSpring GX 11.5, an expansion of its bioinformatics software.
GeneSpring GX 11.5 now interprets exon microarray, proteomics, and metabolomics experiments together, using a familiar interface, the company said. GeneSpring GX continues to support applications for gene expression analysis, genomic copy number analysis, genome-wide association analysis, and transcriptomics data analysis.
GeneSpring GX 11.5 was developed in conjunction with Strand Scientific Intelligence and is powered by Strand's Avadis platform. The new software also adds advanced data management functions such as a comprehensive backup utility and an enhanced data-migration tool, Agilent said. It includes integration with GeneGo's MetaCore pathway analysis tool, giving users the ability to combine statistical analysis in GeneSpring with MetaCore's strengths in pathway analysis.
Cellix this week launched its Vena4Y and the Vena4Y2 biochips for thrombosis and atherosclerosis research, including the study of platelet adhesion, aggregation and thrombi formation.
According to the Irish firm, its platform integrates flow-based cell adhesion assays with branching microchannels that mimic human capillaries. The biochips allow for the precise control of microliter volumes of biochemical samples and reagents, it said.